NYSE:CORHealthcare
How Investors Are Reacting To Cencora (COR) US$3 Billion Senior Notes To Term Out Acquisition Debt
Cencora, Inc. recently priced US$3.00 billion of fixed-rate senior unsecured notes across maturities from 2029 to 2056, primarily to refinance short-term acquisition funding for OneOncology and support general corporate purposes, with the offering expected to close on February 13, 2026, subject to customary conditions.
This move, alongside the first-quarter results showing higher sales, net income and earnings per share and a maintained quarterly dividend, highlights Cencora’s focus on...